MedTrace Logo

Effects of Simvastatin on Biochemical Parameters and Outcome of IVF-ICSI in Pcos Patients

NCT00575601 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2009-07-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether simvastatin is effective in the improvement of IVF-ICSI outcome in Pcos patients.

Conditions

  • Polycystic Ovary Syndrome

Interventions

DRUG

SIMVASTATIN

20 mg/day,po,for two months until the day of hCG injection placebo pills as like as simvastatin will be used

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    lead OTHER

Principal Investigators

  • batool hossein rashidi, MD · Tehran University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Completion
2009-04-30

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00575601 on ClinicalTrials.gov